0

Close
 
Upcoming Allied Market Research
2023
Beta-alanine Market

Beta-Alanine Market

by Product Type (FOOD GRADE BETA-ALANINE, PHARMACEUTICAL GRADE BETA-ALANINE, FEED GRADE BETA-ALANINE, OTHERS) and by End Use Industry (FOOD BEVERAGE, PHARMACEUTICAL, PERSONAL CARE, ANIMAL FEED, CHEMICAL): Global Opportunity Analysis and Industry Forecast, 2023-2032

MC : Renewable, Speciality and fine chemicals
Report Code: A02580
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Beta-alanine Market

Request Now !

Beta-alanine also referred as 3-aminopropanoic acid is a non-essential, naturally occurring beta amino acid formed through degradation of carnosine and dihydrouracil. It is industrially produced as a result of reaction between ammonia and beta-propiolactone.

It is available in powdered form in the market and is soluble in water, ethanol and methanol. Beta-alanine is utilized as a food additive for imitation of mushroom & beef flavours and to fortify flavouring in gravies & other substances. It is also used for enhancing exercise capacity & athletic performance, improving physical functioning in elder population and building lean muscle mass.

Increasing awareness regarding protein health benefits among youth and rising importance of active lifestyles are major factors which drive the growth of beta-alanine market. Growth in pharmaceutical sector and rapid urbanization are other factors which supplement market growth.

Asia-Pacific is expected to register substantial growth owing to increasing disposable incomes and rising adoption of westernized lifestyle in emerging economies such as China and India. High dose of beta-alanine can cause taurine deficiency and paresthesia, a potentially uncomfortable tingling of skin which usually affect face, abdomen & chest. This can hinder the market growth.

However, rising applications of beta-alanine across various end-user industries and growing number of individuals seeking to participate in sports are factors expected to provide potential growth opportunities for market expansion.

The report segments the beta-alanine market on the basis of product type, end-use industry and geography. Based on product type, it is divided into food grade beta-alanine, pharmaceutical grade beta-alanine, feed grade beta-alanine and others. On the basis of end-use industry, the market is bifurcated into food & beverage, pharmaceutical, personal care, animal feed and chemical. Geographical breakdown of the market includes North America, Europe, Asia-Pacific, and LAMEA.

Comprehensive competitive analysis and profiles of major market players such as Anhui Huaheng Biotechnology Co., Ltd., Haolong Biotechnology Co. Ltd., Natural Alternatives International, Inc., Shandong Yangcheng Biotech Co., Ltd., Shanghai Hope Industry Co., Ltd., Wuhan Microsen Technology Co., Ltd., Xinfa Pharmaceutical Co., Ltd., Yangzhou Baosheng Bio-Chemical Co. Ltd., Yuki Gosei Kogyo Co., Ltd., and Zhangjiagang Specom Biochemical Co., Ltd is also provided in the report.

Key Benefits

  • This report provides a quantitative analysis of the current trends and estimations of the global beta-alanine market to identify the prevailing market opportunities.
  • Major countries in each region are mapped according to individual market revenue.
  • Comprehensive analysis of factors that drive and restrict the market growth is provided.
  • An in-depth analysis of current research & clinical developments within the market is provided with key dynamic factors.
  • Key players and their key developments in the recent years are listed.

 Beta-Alanine Market Report Highlights

Aspects Details
By Product Type
  • FOOD GRADE BETA-ALANINE
  • PHARMACEUTICAL GRADE BETA-ALANINE
  • FEED GRADE BETA-ALANINE
  • OTHERS
By End Use Industry
  • FOOD & BEVERAGE
  • PHARMACEUTICAL
  • PERSONAL CARE
  • ANIMAL FEED
  • CHEMICAL
By Geography
  • NORTH AMERICA
    • U.S
    • CANADA
    • MEXICO
  • EUROPE
    • UK
    • GERMANY
    • France
    • Spain
    • Italy
    • REST OF EUROPE
  • ASIA-PACIFIC
    • CHINA
    • JAPAN
    • INDIA
    • AUSTRALIA
    • SOUTH KOREA
    • REST OF ASIA-PACIFIC
  • LAMEA
    • BRAZIL
    • SOUTH AFRICA
    • SAUDI ARABIA
    • REST OF LAMEA
Key Market Players ANHUI HUAHENG BIOTECHNOLOGY CO., LTD., XINFA PHARMACEUTICAL CO., LTD., YANGZHOU BAOSHENG BIO-CHEMICAL CO. LTD., HAOLONG BIOTECHNOLOGY CO. LTD., ZHANGJIAGANG SPECOM BIOCHEMICAL CO., LTD., YUKI GOSEI KOGYO CO., LTD., SHANDONG YANGCHENG BIOTECH CO., LTD., WUHAN MICROSEN TECHNOLOGY CO., LTD., SHANGHAI HOPE INDUSTRY CO., LTD., NATURAL ALTERNATIVES INTERNATIONAL, INC.
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: BETA-ALANINE MARKET, BY PRODUCT TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product Type

    • 4.2. FOOD GRADE BETA-ALANINE

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. PHARMACEUTICAL GRADE BETA-ALANINE

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. FEED GRADE BETA-ALANINE

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. OTHERS

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

  • CHAPTER 5: BETA-ALANINE MARKET, BY END USE INDUSTRY

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By End Use Industry

    • 5.2. FOOD BEVERAGE

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. PHARMACEUTICAL

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. PERSONAL CARE

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. ANIMAL FEED

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

    • 5.6. CHEMICAL

      • 5.6.1. Key Market Trends, Growth Factors and Opportunities

      • 5.6.2. Market Size and Forecast, By Region

      • 5.6.3. Market Share Analysis, By Country

  • CHAPTER 6: BETA-ALANINE MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Product Type

      • 6.2.3. Market Size and Forecast, By End Use Industry

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Beta-alanine Market

        • 6.2.5.1. Market Size and Forecast, By Product Type
        • 6.2.5.2. Market Size and Forecast, By End Use Industry

      • 6.2.6. Canada Beta-alanine Market

        • 6.2.6.1. Market Size and Forecast, By Product Type
        • 6.2.6.2. Market Size and Forecast, By End Use Industry

      • 6.2.7. Mexico Beta-alanine Market

        • 6.2.7.1. Market Size and Forecast, By Product Type
        • 6.2.7.2. Market Size and Forecast, By End Use Industry

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Product Type

      • 6.3.3. Market Size and Forecast, By End Use Industry

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Beta-alanine Market

        • 6.3.5.1. Market Size and Forecast, By Product Type
        • 6.3.5.2. Market Size and Forecast, By End Use Industry

      • 6.3.6. Germany Beta-alanine Market

        • 6.3.6.1. Market Size and Forecast, By Product Type
        • 6.3.6.2. Market Size and Forecast, By End Use Industry

      • 6.3.7. Italy Beta-alanine Market

        • 6.3.7.1. Market Size and Forecast, By Product Type
        • 6.3.7.2. Market Size and Forecast, By End Use Industry

      • 6.3.8. Spain Beta-alanine Market

        • 6.3.8.1. Market Size and Forecast, By Product Type
        • 6.3.8.2. Market Size and Forecast, By End Use Industry

      • 6.3.9. UK Beta-alanine Market

        • 6.3.9.1. Market Size and Forecast, By Product Type
        • 6.3.9.2. Market Size and Forecast, By End Use Industry

      • 6.3.10. Russia Beta-alanine Market

        • 6.3.10.1. Market Size and Forecast, By Product Type
        • 6.3.10.2. Market Size and Forecast, By End Use Industry

      • 6.3.11. Rest Of Europe Beta-alanine Market

        • 6.3.11.1. Market Size and Forecast, By Product Type
        • 6.3.11.2. Market Size and Forecast, By End Use Industry

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Product Type

      • 6.4.3. Market Size and Forecast, By End Use Industry

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Beta-alanine Market

        • 6.4.5.1. Market Size and Forecast, By Product Type
        • 6.4.5.2. Market Size and Forecast, By End Use Industry

      • 6.4.6. Japan Beta-alanine Market

        • 6.4.6.1. Market Size and Forecast, By Product Type
        • 6.4.6.2. Market Size and Forecast, By End Use Industry

      • 6.4.7. India Beta-alanine Market

        • 6.4.7.1. Market Size and Forecast, By Product Type
        • 6.4.7.2. Market Size and Forecast, By End Use Industry

      • 6.4.8. South Korea Beta-alanine Market

        • 6.4.8.1. Market Size and Forecast, By Product Type
        • 6.4.8.2. Market Size and Forecast, By End Use Industry

      • 6.4.9. Australia Beta-alanine Market

        • 6.4.9.1. Market Size and Forecast, By Product Type
        • 6.4.9.2. Market Size and Forecast, By End Use Industry

      • 6.4.10. Thailand Beta-alanine Market

        • 6.4.10.1. Market Size and Forecast, By Product Type
        • 6.4.10.2. Market Size and Forecast, By End Use Industry

      • 6.4.11. Malaysia Beta-alanine Market

        • 6.4.11.1. Market Size and Forecast, By Product Type
        • 6.4.11.2. Market Size and Forecast, By End Use Industry

      • 6.4.12. Indonesia Beta-alanine Market

        • 6.4.12.1. Market Size and Forecast, By Product Type
        • 6.4.12.2. Market Size and Forecast, By End Use Industry

      • 6.4.13. Rest of Asia Pacific Beta-alanine Market

        • 6.4.13.1. Market Size and Forecast, By Product Type
        • 6.4.13.2. Market Size and Forecast, By End Use Industry

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Product Type

      • 6.5.3. Market Size and Forecast, By End Use Industry

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Beta-alanine Market

        • 6.5.5.1. Market Size and Forecast, By Product Type
        • 6.5.5.2. Market Size and Forecast, By End Use Industry

      • 6.5.6. South Africa Beta-alanine Market

        • 6.5.6.1. Market Size and Forecast, By Product Type
        • 6.5.6.2. Market Size and Forecast, By End Use Industry

      • 6.5.7. Saudi Arabia Beta-alanine Market

        • 6.5.7.1. Market Size and Forecast, By Product Type
        • 6.5.7.2. Market Size and Forecast, By End Use Industry

      • 6.5.8. UAE Beta-alanine Market

        • 6.5.8.1. Market Size and Forecast, By Product Type
        • 6.5.8.2. Market Size and Forecast, By End Use Industry

      • 6.5.9. Argentina Beta-alanine Market

        • 6.5.9.1. Market Size and Forecast, By Product Type
        • 6.5.9.2. Market Size and Forecast, By End Use Industry

      • 6.5.10. Rest of LAMEA Beta-alanine Market

        • 6.5.10.1. Market Size and Forecast, By Product Type
        • 6.5.10.2. Market Size and Forecast, By End Use Industry

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning,2022

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. ANHUI HUAHENG BIOTECHNOLOGY CO., LTD.

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. HAOLONG BIOTECHNOLOGY CO. LTD.

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. NATURAL ALTERNATIVES INTERNATIONAL, INC.

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. SHANDONG YANGCHENG BIOTECH CO., LTD.

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. SHANGHAI HOPE INDUSTRY CO., LTD.

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. WUHAN MICROSEN TECHNOLOGY CO., LTD.

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. XINFA PHARMACEUTICAL CO., LTD.

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. YANGZHOU BAOSHENG BIO-CHEMICAL CO. LTD.

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. YUKI GOSEI KOGYO CO., LTD.

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. ZHANGJIAGANG SPECOM BIOCHEMICAL CO., LTD.

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL BETA-ALANINE MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL BETA-ALANINE MARKET FOR FOOD GRADE BETA-ALANINE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL BETA-ALANINE MARKET FOR PHARMACEUTICAL GRADE BETA-ALANINE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL BETA-ALANINE MARKET FOR FEED GRADE BETA-ALANINE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL BETA-ALANINE MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL BETA-ALANINE MARKET, BY END USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL BETA-ALANINE MARKET FOR FOOD BEVERAGE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL BETA-ALANINE MARKET FOR PHARMACEUTICAL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL BETA-ALANINE MARKET FOR PERSONAL CARE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL BETA-ALANINE MARKET FOR ANIMAL FEED, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL BETA-ALANINE MARKET FOR CHEMICAL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL BETA-ALANINE MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. NORTH AMERICA BETA-ALANINE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. NORTH AMERICA BETA-ALANINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 15. NORTH AMERICA BETA-ALANINE, BY END USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 16. U.S. BETA-ALANINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 17. U.S. BETA-ALANINE, BY END USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 18. CANADA BETA-ALANINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 19. CANADA BETA-ALANINE, BY END USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 20. MEXICO BETA-ALANINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 21. MEXICO BETA-ALANINE, BY END USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 22. EUROPE BETA-ALANINE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 23. EUROPE BETA-ALANINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 24. EUROPE BETA-ALANINE, BY END USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 25. FRANCE BETA-ALANINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 26. FRANCE BETA-ALANINE, BY END USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 27. GERMANY BETA-ALANINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 28. GERMANY BETA-ALANINE, BY END USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 29. ITALY BETA-ALANINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 30. ITALY BETA-ALANINE, BY END USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 31. SPAIN BETA-ALANINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 32. SPAIN BETA-ALANINE, BY END USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 33. UK BETA-ALANINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 34. UK BETA-ALANINE, BY END USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 35. RUSSIA BETA-ALANINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 36. RUSSIA BETA-ALANINE, BY END USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 37. REST OF EUROPE BETA-ALANINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 38. REST OF EUROPE BETA-ALANINE, BY END USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 39. ASIA-PACIFIC BETA-ALANINE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 40. ASIA-PACIFIC BETA-ALANINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 41. ASIA-PACIFIC BETA-ALANINE, BY END USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 42. CHINA BETA-ALANINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 43. CHINA BETA-ALANINE, BY END USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 44. JAPAN BETA-ALANINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 45. JAPAN BETA-ALANINE, BY END USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 46. INDIA BETA-ALANINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 47. INDIA BETA-ALANINE, BY END USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 48. SOUTH KOREA BETA-ALANINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 49. SOUTH KOREA BETA-ALANINE, BY END USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 50. AUSTRALIA BETA-ALANINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 51. AUSTRALIA BETA-ALANINE, BY END USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 52. THAILAND BETA-ALANINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 53. THAILAND BETA-ALANINE, BY END USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 54. MALAYSIA BETA-ALANINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 55. MALAYSIA BETA-ALANINE, BY END USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 56. INDONESIA BETA-ALANINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 57. INDONESIA BETA-ALANINE, BY END USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 58. REST OF ASIA PACIFIC BETA-ALANINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 59. REST OF ASIA PACIFIC BETA-ALANINE, BY END USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 60. LAMEA BETA-ALANINE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 61. LAMEA BETA-ALANINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 62. LAMEA BETA-ALANINE, BY END USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 63. BRAZIL BETA-ALANINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 64. BRAZIL BETA-ALANINE, BY END USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 65. SOUTH AFRICA BETA-ALANINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 66. SOUTH AFRICA BETA-ALANINE, BY END USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 67. SAUDI ARABIA BETA-ALANINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 68. SAUDI ARABIA BETA-ALANINE, BY END USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 69. UAE BETA-ALANINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 70. UAE BETA-ALANINE, BY END USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 71. ARGENTINA BETA-ALANINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 72. ARGENTINA BETA-ALANINE, BY END USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 73. REST OF LAMEA BETA-ALANINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 74. REST OF LAMEA BETA-ALANINE, BY END USE INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 75. ANHUI HUAHENG BIOTECHNOLOGY CO., LTD.: KEY EXECUTIVES
  • TABLE 76. ANHUI HUAHENG BIOTECHNOLOGY CO., LTD.: COMPANY SNAPSHOT
  • TABLE 77. ANHUI HUAHENG BIOTECHNOLOGY CO., LTD.: OPERATING SEGMENTS
  • TABLE 78. ANHUI HUAHENG BIOTECHNOLOGY CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 79. ANHUI HUAHENG BIOTECHNOLOGY CO., LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 80. HAOLONG BIOTECHNOLOGY CO. LTD.: KEY EXECUTIVES
  • TABLE 81. HAOLONG BIOTECHNOLOGY CO. LTD.: COMPANY SNAPSHOT
  • TABLE 82. HAOLONG BIOTECHNOLOGY CO. LTD.: OPERATING SEGMENTS
  • TABLE 83. HAOLONG BIOTECHNOLOGY CO. LTD.: PRODUCT PORTFOLIO
  • TABLE 84. HAOLONG BIOTECHNOLOGY CO. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 85. NATURAL ALTERNATIVES INTERNATIONAL, INC.: KEY EXECUTIVES
  • TABLE 86. NATURAL ALTERNATIVES INTERNATIONAL, INC.: COMPANY SNAPSHOT
  • TABLE 87. NATURAL ALTERNATIVES INTERNATIONAL, INC.: OPERATING SEGMENTS
  • TABLE 88. NATURAL ALTERNATIVES INTERNATIONAL, INC.: PRODUCT PORTFOLIO
  • TABLE 89. NATURAL ALTERNATIVES INTERNATIONAL, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 90. SHANDONG YANGCHENG BIOTECH CO., LTD.: KEY EXECUTIVES
  • TABLE 91. SHANDONG YANGCHENG BIOTECH CO., LTD.: COMPANY SNAPSHOT
  • TABLE 92. SHANDONG YANGCHENG BIOTECH CO., LTD.: OPERATING SEGMENTS
  • TABLE 93. SHANDONG YANGCHENG BIOTECH CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 94. SHANDONG YANGCHENG BIOTECH CO., LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 95. SHANGHAI HOPE INDUSTRY CO., LTD.: KEY EXECUTIVES
  • TABLE 96. SHANGHAI HOPE INDUSTRY CO., LTD.: COMPANY SNAPSHOT
  • TABLE 97. SHANGHAI HOPE INDUSTRY CO., LTD.: OPERATING SEGMENTS
  • TABLE 98. SHANGHAI HOPE INDUSTRY CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 99. SHANGHAI HOPE INDUSTRY CO., LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 100. WUHAN MICROSEN TECHNOLOGY CO., LTD.: KEY EXECUTIVES
  • TABLE 101. WUHAN MICROSEN TECHNOLOGY CO., LTD.: COMPANY SNAPSHOT
  • TABLE 102. WUHAN MICROSEN TECHNOLOGY CO., LTD.: OPERATING SEGMENTS
  • TABLE 103. WUHAN MICROSEN TECHNOLOGY CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 104. WUHAN MICROSEN TECHNOLOGY CO., LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 105. XINFA PHARMACEUTICAL CO., LTD.: KEY EXECUTIVES
  • TABLE 106. XINFA PHARMACEUTICAL CO., LTD.: COMPANY SNAPSHOT
  • TABLE 107. XINFA PHARMACEUTICAL CO., LTD.: OPERATING SEGMENTS
  • TABLE 108. XINFA PHARMACEUTICAL CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 109. XINFA PHARMACEUTICAL CO., LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 110. YANGZHOU BAOSHENG BIO-CHEMICAL CO. LTD.: KEY EXECUTIVES
  • TABLE 111. YANGZHOU BAOSHENG BIO-CHEMICAL CO. LTD.: COMPANY SNAPSHOT
  • TABLE 112. YANGZHOU BAOSHENG BIO-CHEMICAL CO. LTD.: OPERATING SEGMENTS
  • TABLE 113. YANGZHOU BAOSHENG BIO-CHEMICAL CO. LTD.: PRODUCT PORTFOLIO
  • TABLE 114. YANGZHOU BAOSHENG BIO-CHEMICAL CO. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 115. YUKI GOSEI KOGYO CO., LTD.: KEY EXECUTIVES
  • TABLE 116. YUKI GOSEI KOGYO CO., LTD.: COMPANY SNAPSHOT
  • TABLE 117. YUKI GOSEI KOGYO CO., LTD.: OPERATING SEGMENTS
  • TABLE 118. YUKI GOSEI KOGYO CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 119. YUKI GOSEI KOGYO CO., LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 120. ZHANGJIAGANG SPECOM BIOCHEMICAL CO., LTD.: KEY EXECUTIVES
  • TABLE 121. ZHANGJIAGANG SPECOM BIOCHEMICAL CO., LTD.: COMPANY SNAPSHOT
  • TABLE 122. ZHANGJIAGANG SPECOM BIOCHEMICAL CO., LTD.: OPERATING SEGMENTS
  • TABLE 123. ZHANGJIAGANG SPECOM BIOCHEMICAL CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 124. ZHANGJIAGANG SPECOM BIOCHEMICAL CO., LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL BETA-ALANINE MARKET SEGMENTATION
  • FIGURE 2. GLOBAL BETA-ALANINE MARKET
  • FIGURE 3. SEGMENTATION BETA-ALANINE MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN BETA-ALANINE MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALBETA-ALANINE MARKET
  • FIGURE 11. BETA-ALANINE MARKET SEGMENTATION, BY BY PRODUCT TYPE
  • FIGURE 12. BETA-ALANINE MARKET FOR FOOD GRADE BETA-ALANINE, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. BETA-ALANINE MARKET FOR PHARMACEUTICAL GRADE BETA-ALANINE, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. BETA-ALANINE MARKET FOR FEED GRADE BETA-ALANINE, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. BETA-ALANINE MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. BETA-ALANINE MARKET SEGMENTATION, BY BY END USE INDUSTRY
  • FIGURE 17. BETA-ALANINE MARKET FOR FOOD BEVERAGE, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. BETA-ALANINE MARKET FOR PHARMACEUTICAL, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. BETA-ALANINE MARKET FOR PERSONAL CARE, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. BETA-ALANINE MARKET FOR ANIMAL FEED, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. BETA-ALANINE MARKET FOR CHEMICAL, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 23. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 24. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 25. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 26. COMPETITIVE DASHBOARD
  • FIGURE 27. COMPETITIVE HEATMAP: BETA-ALANINE MARKET
  • FIGURE 28. Top player positioning, 2022
  • FIGURE 29. ANHUI HUAHENG BIOTECHNOLOGY CO., LTD.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 30. ANHUI HUAHENG BIOTECHNOLOGY CO., LTD.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 31. ANHUI HUAHENG BIOTECHNOLOGY CO., LTD.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 32. HAOLONG BIOTECHNOLOGY CO. LTD.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 33. HAOLONG BIOTECHNOLOGY CO. LTD.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 34. HAOLONG BIOTECHNOLOGY CO. LTD.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 35. NATURAL ALTERNATIVES INTERNATIONAL, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 36. NATURAL ALTERNATIVES INTERNATIONAL, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 37. NATURAL ALTERNATIVES INTERNATIONAL, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 38. SHANDONG YANGCHENG BIOTECH CO., LTD.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 39. SHANDONG YANGCHENG BIOTECH CO., LTD.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 40. SHANDONG YANGCHENG BIOTECH CO., LTD.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 41. SHANGHAI HOPE INDUSTRY CO., LTD.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 42. SHANGHAI HOPE INDUSTRY CO., LTD.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 43. SHANGHAI HOPE INDUSTRY CO., LTD.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 44. WUHAN MICROSEN TECHNOLOGY CO., LTD.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 45. WUHAN MICROSEN TECHNOLOGY CO., LTD.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 46. WUHAN MICROSEN TECHNOLOGY CO., LTD.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 47. XINFA PHARMACEUTICAL CO., LTD.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 48. XINFA PHARMACEUTICAL CO., LTD.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 49. XINFA PHARMACEUTICAL CO., LTD.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 50. YANGZHOU BAOSHENG BIO-CHEMICAL CO. LTD.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 51. YANGZHOU BAOSHENG BIO-CHEMICAL CO. LTD.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 52. YANGZHOU BAOSHENG BIO-CHEMICAL CO. LTD.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 53. YUKI GOSEI KOGYO CO., LTD.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 54. YUKI GOSEI KOGYO CO., LTD.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 55. YUKI GOSEI KOGYO CO., LTD.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 56. ZHANGJIAGANG SPECOM BIOCHEMICAL CO., LTD.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 57. ZHANGJIAGANG SPECOM BIOCHEMICAL CO., LTD.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 58. ZHANGJIAGANG SPECOM BIOCHEMICAL CO., LTD.: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Beta-alanine Market

Start reading.
This Report and over 67,518+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers